Please assess the completion status of the following clinical trial:

Trial Title: A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects of either gender at least 18 years at the time of signing the informed consent.~* Having a clinical indication for CT-examination of the abdomen~Exclusion Criteria:~* IV administration of iodine is contraindicated~* Known allergy to egg albumen~* Clinical suspicion, according to medical record, of fistula formation and/or leakage~* Referral indication of small bowel disease(s)~* Having known manifest thyrotoxicosis~* Having known phenylketonuria~* Having known Glucose-6-phosphatase deficiency

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lumentin® 44 (Type: EXPERIMENTAL): Contrast agent
- Diluted Omnipaque® (Type: ACTIVE_COMPARATOR): Contrast agent
- Movprep® (Type: ACTIVE_COMPARATOR): Contrast agent

Based on this trial design, predict the completion outcome and termination type (if applicable).